CAsein GLycomacropeptide in Ulcerative Colitis - Anti-Inflammatory and Microbiome Modulating Effects (CAGLUCIM)

NCT02825914 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Colitis, Ulcerative
Inflammatory Bowel Diseases

Interventions

DIETARY_SUPPLEMENT: Casein glycomacropeptide (CGMP)
DIETARY_SUPPLEMENT: Placebo

Sponsor

University of Aarhus